The Annual General Meeting of RaySearch Laboratories AB (publ), which was held on May 22, 2008, passed the following resolutions, among others.
It was resolved that the number of Board members shall be four (4) and the number of deputy members shall be one (1). Johan Löf, Erik Hedlund, Carl Filip Bergendal and Hans Wigzell were re-elected members of the Board, with Erik Hedlund as Chairman of the Board. Thomas Pousette was re-elected deputy member of the Board.
The Annual General Meeting resolved that the director fees to be paid to Board members who do not receive a salary from any Group company shall total SEK 550,000 for the period until the next Annual General Meeting, of which the Chairman of the Board shall receive SEK 330,000 and each other elected Board member who does not receive a salary from any company in the Group shall receive
SEK 110,000.
In accordance with the proposal by the Board of Directors and the President, the Annual General Meeting decided that a dividend be paid to the company’s shareholders of SEK 0.50 per share, or a total of SEK 5,714,000. It was decided that the remaining amount of accumulated profits, SEK 951,000, be carried forward. It was decided that the Annual General Meeting authorize the Board to determine a record date and payment date for the dividend. It was the Board’s opinion that the dividend is justifiable taking into account the demands that the type of operations, scope and risks place on the size of the Parent Company’s and Group’s equity and the Parent Company’s and Group’s consolidation requirements, liquidity and financial position in general.
The Board of Directors and the President were discharged from personal liability for the 2007 fiscal year.
The Annual General Meeting decided about guidelines for remuneration to senior executives.
Anders Linér was re-elected as auditor and as deputy auditor Lena Krause was re-elected.
For the purpose of achieving a number of shares that is appropriate for the company, the Meeting decided to increase the number of shares in the company through a split of each share into three (3) shares, whereby the number of the shares in the company increases to 34,282,773, of which 12,638,724 Series A and 21,644,049 Series B, each with a quota value of SEK 0.50, and that the wording of Section 4, first paragraph second point in the company’s Articles of Association regarding the number of shares be changed as follows: “The number of shares shall be not less than 18,000,000 and not more than 72,000,000.” In addition, the Meeting authorized the Board to decide on the record date for the split and to take the other measures necessary to implement the split.
ABOUT RAYSEARCH
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are sold through license agreements with leading partners such as Philips, Varian, Nucletron, IBA Dosimetry and TomoTherapy. Eight products have been released to date and RaySearch’s software is used at over 1,300 clinics in more than 30 countries. In addition, existing license agreements cover more than 15 other products that are scheduled to be launched in the coming years. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the SmallCap segment on the OMX Nordic Exchange Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com.
FOR FURTHER INFORMATION, CONTACT:
Johan Löf, President and CEO, RaySearch Laboratories AB
Telephone: +46 (0)8-545 061 30
johan.lof@raysearchlabs.com
Press releases
